S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

PTN Palatin Technologies Inc New

1.37

0.07 (5.38%)

Jan 03 2025 - Closed

Delayed by 15 minutes

Form 424B3 - Prospectus [Rule 424(b)(3)]

null

Palatin Technologies (AMEX:PTN)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Palatin Technologies Charts.

Palatin Technologies (AMEX:PTN)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Palatin Technologies Charts.

Palatin Technologies Inc New News

Palatin Announces Positive Phase IIb BREAKOUT Study Results in Patients with Type 2 Diabetic Nephropathy
Thursday 19 December 2024 (2 weeks ago) • PR Newswire (US)

Form 8-K - Current report
Monday 16 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Palatin Announces Exercise of Warrants for Approximately $3.4 Million Gross Proceeds
Monday 16 December 2024 (3 weeks ago) • PR Newswire (US)

Palatin Announces Completion of Patient Enrollment in Phase 2 Study of Orally Administered Melanocortin Agonist PL8177 in Ulcerative Colitis
Monday 25 November 2024 (1 month ago) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Palatin Reports First Quarter Fiscal Year 2025 Operating/Financial Results
Thursday 14 November 2024 (2 months ago) • PR Newswire (US)

Palatin to Report First Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on November 14, 2024
Friday 8 November 2024 (2 months ago) • PR Newswire (US)

Palatin Presents Data on Novel Melanocortin 4 Receptor Selective Oral Small Molecule PL7737 Obesity Program at ObesityWeek® 2024
Monday 4 November 2024 (2 months ago) • PR Newswire (US)

Palatin Completes Enrollment in Phase 2 Clinical Study of Bremelanotide (MC4R Agonist) Co-Administered with Tirzepatide (GLP-1/GIP) for the Treatment of Obesity
Thursday 31 October 2024 (2 months ago) • PR Newswire (US)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Wednesday 30 October 2024 (2 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Tuesday 29 October 2024 (2 months ago) • Edgar (US Regulatory)

More Palatin Technologies Inc New News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions